- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Europe better prepared than ever to ensure COVID vaccine reaches population: Sanofi
Paris: Europe is better prepared than ever to ensure a COVID-19 vaccine reaches the population, Sanofi's chief executive said on Monday.
A few months after taking over at the French drugmaker, Paul Hudson irked French authorities earlier this year after saying the American public was likely to receive vaccine shots first given the U.S. government provided early funding.
The company at swiftly reassured the market that a Sanofi vaccine would be made available to anyone who needs it.
There is no internationally-approved vaccine to prevent COVID-19, the illness caused by the coronavirus that has killed more than 1.2 million, derailed the world economy and turned the daily lives of billions upside down.
Earlier on Monday Pfizer Inc and German partner BioNTech SE said their experimental COVID-19 vaccine was more than 90% effective. The companies said they have so far found no serious safety concerns and expect to seek U.S. authorization this month for emergency use of the vaccine.
Many drugmakers are already producing vaccines doses at scale even though trials are ongoing with the possibility of having to destroy output if trials disappoint.
"We are in a completely different position than we were when we first began our dialogue at the beginning of the year," Paul Hudson said at a panel organised by the Financial Times.
"Now, we are as good and far as we can be. And we can just look at the biology," he said.
Sanofi, which is developing two COVID-19 vaccines, including one with Britain's GlaxoSMithKline, reached an advance purchase agreement with the European Union in September to provide the bloc with 300 million doses.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751